By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Becton Dickinson reported after the close of the market Tuesday that its second-quarter revenues swelled 7 percent overall, driven in part by a 9 percent increase in its BD Diagnostics business year over year.

BD had total revenues of $1.92 billion for the three-month period ended March 31, compared to $1.8 billion for the second quarter of 2010. Analysts had expected the company to earn revenues of $1.86 billion for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.